SHRIDHAR BHAT: Open Payments
NPI 1134158991 · RICH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 13 payments from 8 companies in 2025. Trend: 2023 $879 · 2024 $940 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| EMD Serono, Inc. | 2 | $121 |
| ABBVIE INC. | 2 | $51 |
| Indivior Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: Kerendia, HYQVIA, Mavenclad, QULIPTA, SUBLOCADE, CAPLYTA, Auvelity, Rybelsus.
Industry payments across VA — which companies pay providers there.
